These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 38260239)

  • 21. Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies.
    Liao J; Fan L; Li Y; Xu QQ; Xiong LY; Zhang SS; Liu JH; Xiao ZC; Zhang C; Yang J; Chen ZS; Xiao K; Wang TF; Lu Y
    J Control Release; 2023 Jun; 358():439-464. PubMed ID: 37169179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease.
    Zhong X; Na Y; Yin S; Yan C; Gu J; Zhang N; Geng F
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor.
    Siddique AR; Bhagwat GS
    Adv Pharm Bull; 2024 Mar; 14(1):132-146. PubMed ID: 38585450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases.
    Fang Z; Fang J; Gao C; Gao R; Lin P; Yu W
    Drug Deliv; 2022 Dec; 29(1):2805-2814. PubMed ID: 36047245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy.
    Liu X; Xiao C; Xiao K
    J Nanobiotechnology; 2023 Aug; 21(1):287. PubMed ID: 37608298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomimetic Nanoparticle Drug Delivery Systems to Overcome Biological Barriers for Therapeutic Applications.
    Fukuta T; Kogure K
    Chem Pharm Bull (Tokyo); 2022; 70(5):334-340. PubMed ID: 35491189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.
    Song M; Dong S; An X; Zhang W; Shen N; Li Y; Guo C; Liu C; Li X; Chen S
    J Control Release; 2022 May; 345():744-754. PubMed ID: 35381274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards protein-based viral mimetics for cancer therapies.
    Unzueta U; Céspedes MV; Vázquez E; Ferrer-Miralles N; Mangues R; Villaverde A
    Trends Biotechnol; 2015 May; 33(5):253-8. PubMed ID: 25805413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomimetic camouflage delivery strategies for cancer therapy.
    Asrorov AM; Gu Z; Li F; Liu L; Huang Y
    Nanoscale; 2021 May; 13(19):8693-8706. PubMed ID: 33949576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application and Development of Cell Membrane Functionalized Biomimetic Nanoparticles in the Treatment of Acute Ischemic Stroke.
    Li Y; Wu C; Yang R; Tang J; Li Z; Yi X; Fan Z
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy.
    Huang X; Guo H; Wang L; Zhang Z; Zhang W
    Drug Discov Today; 2023 Apr; 28(4):103514. PubMed ID: 36736580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication.
    Mengyuan H; Aixue L; Yongwei G; Qingqing C; Huanhuan C; Xiaoyan L; Jiyong L
    J Nanobiotechnology; 2024 Oct; 22(1):604. PubMed ID: 39370518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Fate of Nanoparticles In Vivo and the Strategy of Designing Stealth Nanoparticle for Drug Delivery.
    Bao J; Zhang Q; Duan T; Hu R; Tang J
    Curr Drug Targets; 2021; 22(8):922-946. PubMed ID: 33461465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy.
    Oroojalian F; Beygi M; Baradaran B; Mokhtarzadeh A; Shahbazi MA
    Small; 2021 Mar; 17(12):e2006484. PubMed ID: 33577127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic chemotherapy and phototherapy based on red blood cell biomimetic nanomaterials.
    Meng D; Yang S; Yang Y; Zhang L; Cui L
    J Control Release; 2022 Dec; 352():146-162. PubMed ID: 36252749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-derived biomimetic nanoparticles for the targeted therapy of ALI/ARDS.
    Gao R; Lin P; Fang Z; Yang W; Gao W; Wang F; Pan X; Yu W
    Drug Deliv Transl Res; 2024 Jun; 14(6):1432-1457. PubMed ID: 38117405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomimetic cell-derived nanocarriers in cancer research.
    Soprano E; Polo E; Pelaz B; Del Pino P
    J Nanobiotechnology; 2022 Dec; 20(1):538. PubMed ID: 36544135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-nanocarrier drug delivery system: a promising strategy for cancer therapy.
    Yang J; Shi X; Kuang Y; Wei R; Feng L; Chen J; Wu X
    Drug Deliv Transl Res; 2024 Mar; 14(3):581-596. PubMed ID: 37721694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From blood to brain: blood cell-based biomimetic drug delivery systems.
    Li YJ; Wu JY; Liu J; Qiu X; Xu W; Tang T; Xiang DX
    Drug Deliv; 2021 Dec; 28(1):1214-1225. PubMed ID: 34142628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.